WINNING STRATEGIES WASHINGTON

Lobbying for DBV TECHNOLOGIES · Pharmaceutical Company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $40,000.00 income · posted Jan 19, 2026

Lobbying activity 1

Health Issues

Innovation in medical therapies to treat childhood food allergies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem